UHT - NYSE

Universal Health Realty Income Trust

UHT·NYSE

$40.26

-0.84%

Real EstateREIT - Healthcare Facilities

Universal Health Realty Income Trust, a real estate investment trust, invests in healthcare and human service related facilities including acute care hospitals, rehabilitation hospitals, sub-acute care facilities, medical/office buildings, free-standing emergency departments and childcare centers. We have investments in seventy-one properties located in twenty states, including two that are currently under construction.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$558.59M

EPS1.2700

P/E Ratio31.70

Earnings Date07/27/2026

99.19M

Revenue

3Y+9.0%

5Y+27.0%

10Y+48.0%

17.61M

Net Income

-8%

3Y-17.0%

5Y-9.0%

10Y+2.0%

49.09M

Operating Cash Flow

3Y+5.0%

5Y+11.0%

10Y+21.0%

Universal Health Realty Income Trust Profit Bridge

UHT · NYSE

Revenue & Cost of Sales

Revenue99.19M

Cost of Goods Sold (5.59M)

Gross Profit93.59M

Operating Expenses

Operating Expenses (58.83M)

Operating Income34.76M

Other Income & Taxes

Interest Expense (21.87M)

Other Income/Expense-17.15M

Pretax Income17.61M

Income Tax (0.00)

Net Income17.61M

Net Income

17.61M

Profitability Analysis

Gross Margin

94.4%

Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.

Operating Margin

35.0%

Outstanding operational efficiency. The company generates substantial profit from core operations.

Net Profit Margin

17.8%

Strong net margins indicate efficient operations and favorable tax/interest management.

Effective Tax Rate

0.0%

Below-average tax rate suggests effective tax planning, favorable jurisdictions, or tax credits.

Profitability Insight

Exceptional profitability across all levels: Strong pricing power, efficient operations, and healthy bottom line indicate a high-quality business with sustainable competitive advantages.

Universal Health Realty Income Trust Income Statement

UHT • NYSE

Universal Health Realty Income Trust Income Statement	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009	Dec 2008	Dec 2007	Dec 2006
REVENUE
Revenue	99.2M	99M	95.6M	90.6M	84.2M	78M	77.2M	76.2M	72.3M	67.1M	64M	59.8M	54.3M	54M	29.5M	28.9M	31.9M	29.2M	28M	31.7M
GROSS PROFIT
Cost of Revenue	(5.6M)	(5.5M)	(5.3M)	(5.1M)	(4.4M)	(4.1M)	(4M)	(3.8M)	(3.6M)	(3.3M)	(2.8M)	(2.5M)	(2.4M)	(2.1M)	(2M)	(1.9M)	(0.0)	(0.0)	(0.0)	(0.0)
Gross Profit	93.6M	93.5M	90.3M	85.5M	79.8M	73.9M	73.2M	72.4M	68.8M	63.8M	61.1M	57.2M	51.9M	51.8M	27.5M	27M	31.9M	29.2M	28M	31.7M
OPERATING INCOME
Operating Expenses	(58.8M)	(56.7M)	(58.9M)	(54.9M)	(50.9M)	(47.9M)	(47.4M)	(45.7M)	(44.7M)	(41.7M)	(40.5M)	(38.2M)	(33.4M)	(35.5M)	(18.8M)	(11.7M)	(14M)	(17.2M)	(11.1M)	(13M)
Selling, General & Administrative	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(4.1M)	(4M)	(3.8M)	(3.6M)	(3.3M)	(2.8M)	(2.5M)	(2.4M)	(2.1M)	(2.5M)	(1.9M)	(1.6M)	(1.6M)	(1.4M)	(0.0)
Operating Income	34.8M	36.8M	31.3M	30.7M	28.9M	26M	25.8M	26.7M	24M	22.1M	20.6M	19M	18.5M	16.4M	8.7M	15.3M	17.9M	12M	16.8M	18.7M
PRE-TAX INCOME
Interest Expense	(21.9M)	(23.8M)	(22M)	(10.8M)	(8.8M)	(8.3M)	(10.5M)	(9.7M)	(10.1M)	(9.4M)	(8.2M)	(8.4M)	(7.5M)	(7.8M)	(2.4M)	(1.9M)	(2.4M)	(2.4M)	(1.7M)	(2.3M)
Net Interest Income	-16.5M	-18.1M	-16.2M	-9.7M	-8.8M	-8.2M	-10.3M	-9.3M	-10.1M	-9.4M	-8.2M	-8.4M	-7.5M	-7.8M	-2.4M	-1.9M	-2.4M	-2.4M	-1.7M	-2.3M
Other Expenses	(58.8M)	(56.7M)	(58.9M)	(54.9M)	(50.9M)	(43.7M)	(43.5M)	(41.9M)	(41.2M)	(38.4M)	(37.7M)	(35.6M)	(31M)	(33.4M)	(16.2M)	(9.9M)	(12.4M)	(15.6M)	(9.7M)	(13M)
Total Other Income Expenses Net	-17.2M	-17.6M	-15.9M	-9.6M	80.3M	-6.6M	-6.8M	-2.5M	21.6M	-4.9M	3.1M	32.5M	-5.4M	3.1M	65.1M	1M	644K	-339K	0.0	0.0
Income Before Tax	17.6M	19.2M	15.4M	21.1M	109.2M	19.4M	19M	24.2M	45.6M	17.2M	23.7M	51.6M	13.2M	19.5M	73.8M	16.3M	18.6M	11.7M	16.8M	18.7M
NET INCOME
Income Tax Expense	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	-2.8M	-15.7M
Net Income	17.6M	19.2M	15.4M	21.1M	109.2M	19.4M	19M	24.2M	45.6M	17.2M	23.7M	51.6M	13.2M	19.5M	73.8M	16.3M	18.6M	11.7M	22.2M	34.7M

SEC Filings

UHT - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
10-Q 10-Q 2026 Q1 Q1	May 07, 2026	March 31, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	April 28, 2026	June 10, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 27, 2026	April 27, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 24, 2026	April 21, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 25, 2026	February 25, 2026	2026	View Filing
10-K 10-K 2025 FY FY	February 25, 2026	December 31, 2025	2025	View Filing
10-Q 10-Q 2025 Q3 Q3	November 07, 2025	September 30, 2025	2025	View Filing
8-K 8-K 2025 N/A	October 27, 2025	October 27, 2025	2025	View Filing
10-Q 10-Q 2025 Q2 Q2	August 08, 2025	June 30, 2025	2025	View Filing
8-K 8-K 2025 N/A	July 28, 2025	July 28, 2025	2025	View Filing

Showing 1 to 10 of 322 filings

Related Guides

Blog Categories

Continue your UHT research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.